Scentian Bio
Founded 2021 · 18 employees on LinkedIn · 12 known investors
Find your way into Scentian Bio
1,287 people in our graph share verified history with the Scentian Bio team — schools, employers, funds. One of them is your warm intro.
Scentian Bio combines synthetic biology and AI to develop biosensors based on synthesized insect odorant receptors, creating a digital sense of smell and taste that can detect and measure the concentration of thousands of compounds. Spun out of Plant & Food Research, the company holds patents around its odorant-receptor biosensing technology.
Founders & leadership
Scentian Bio was founded in 2021 by Andrew Králíček.




Investors · 12
Also in the syndicate · 5
Funding
SEC filings, press & company announcements$9.1M disclosed across 2 rounds · 2023–2026
- $7Mpre-Series AApr 2026 · 2 sources
Icehouse Ventures (lead), Booster, Cultivate Ventures, DYDX Capital, K1W1, New Zealand Growth Capital Partners, NZGCP, Toyota Ventures
Source ↗ - $2.1MSeedSep 2023 · 3 sources
Finistere Ventures (lead), Toyota Ventures (lead), Icehouse Ventures, Our Crowd
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Scentian Bio do?
- Scentian Bio combines synthetic biology and AI to develop biosensors based on synthesized insect odorant receptors, creating a digital sense of smell and taste that can detect and measure the concentration of thousands of compounds. Spun out of Plant & Food Research, the company holds patents around its odorant-receptor biosensing technology.
- Who founded Scentian Bio?
- Scentian Bio was founded by Andrew Králíček in 2021.
- Who are Scentian Bio's investors?
- Scentian Bio's investors include Booster Innovation Fund, DYDX Capital, Sprout, Finistere Ventures, Icehouse Ventures, OurCrowd, Toyota Ventures.
- How much funding has Scentian Bio raised?
- Scentian Bio has disclosed $9.1M raised across 2 rounds.





